05 April 2021
|
min read
In this article by Naomi Ackerman for The Evening Standard, Sir Peter Donnelly speaks about the potential of DNA trials to reshape NHS healthcare delivery. The piece explores how polygenic risk scores could help identify individuals at higher risk for common diseases, supporting earlier interventions and more efficient screening.
This article was originally published in The Evening Standard.
